High-Cost Drugs
High-Cost Drug Risk Is Now a Business Risk.
High Cost Specialty Drugs & Benefit Plan Sustainability
Over the past decade, high-cost specialty medications have become the largest driver of benefit plan inflation in Canada.
These medications are commonly used to treat conditions such as:
- Rheumatoid arthritis
- Crohn’s disease
- Psoriasis
- Severe asthma
- Autoimmune disorders
While these medications can dramatically improve quality of life, many now cost $20,000 to $80,000+ per patient per year, and some exceed $150,000 annually.
For many employer benefit plans, a single claimant can dramatically impact premiums.
Example
A $60,000 drug claim can equal the annual cost of 15–25 employees on a typical benefits plan.
Because of this, employers across Canada are increasingly reviewing strategies to manage high-cost drug exposure while still ensuring employees receive the medications they need.
Access to Medication Support Programs
The good news is that most specialty medications are supported by manufacturer-funded patient assistance programs.
These programs may provide support with:
- Coordinating insurance coverage
- Exploring available financial assistance
- Understanding potential copayment support
- Navigating provincial drug programs
- Accessing nursing and case management services
Employees who require these medications may wish to contact the applicable support program to learn about available assistance, eligibility requirements and coverage options.
Alberta Drug Coverage Changes: Effective October 1, 2026
Alberta has changed how private and government-sponsored drug and supplemental health coverage work together. Where private or employer coverage is available, it pays first. Government-sponsored programs, including Non-Group Coverage and Coverage for Seniors, are now payers of last resort.
This does not eliminate access to provincial coverage. Eligible expenses remain subject to each program’s coverage rules. For employers, the change may increase claims paid by their benefit plan, making a review of drug coverage and financial protection especially important.
Actively Working Employees and Age Limits
Employers should review age-based termination clauses for affected health benefits covering actively working employees in Alberta. Employees whose coverage previously ended solely because they reached the plan’s age limit may need to be reinstated effective October 1, 2026. An automatic contract amendment does not necessarily reinstate an employee. Confirm affected employees and the required reinstatement steps with your carrier or benefits advisor.
WellnFlex is proactively reviewing client plan designs and carrier updates to identify required actions and opportunities to manage costs. Contact us to review your plan’s coverage, employee eligibility and high-cost drug protection.
Managing Drug Claim Risk for Employers
Many employers are now implementing strategies such as:
- Annual drug maximums
- Managed specialty drug programs or formularies
- Case management for high-cost claims
These approaches can help employers:
- Better manage potential high-cost drug exposure
- Support sustainable benefit plan design
- Improve visibility into potential future costs
High-cost drug protection should be assessed against your specific plan. WellnFlex reviews formularies, pooling or insurance protection, case management and available patient support programs to identify suitable options. Any proposed change should consider both the employer’s costs and employees’ access to treatment.
How WellnFlex Helps
WellnFlex works with employers to:
- Analyze high-cost drug exposure
- Model the financial impact of specialty drug claims
- Compare plan designs that reduce risk
- Identify available patient assistance programs and eligibility considerations
If you would like to review how high-cost drugs may impact your benefit plan, our team would be happy to prepare an analysis.
Common High-Cost Drugs & Support Programs
High-cost specialty medications are becoming increasingly common across employer benefit plans.
Explore individual medications, learn about their associated patient support programs, and discover resources that may help patients navigate coverage and treatment.
Turn High-Cost Drug Risk into Predictable Planning
High-cost drug claims can create significant financial pressure for a benefit plan.
WellnFlex helps employers anticipate exposure, manage costs, and develop sustainable, long-term strategies for their organization.
We focus on, high-cost drug exposure modeling, risk forecasting, claims volatility planning, plan sustainability design, catastrophic claim containment strategies, governance-based benefit structures, long-term cost engineering, renewal risk management
Your benefits are more than coverage, they’re a business asset.
We don’t react to claims, we design systems that absorb them. Let’s protect them together.
Concerned about what these changes mean for your plan?
Contact WellnFlex for a review of your drug coverage and high-cost claims protection.